Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 12, 1998, Pages 1171-1178

  Schulte, C ^a   Reinhardt, W ^a   Beelen, D ^a   Mann, K ^a   Schaefer, U ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

BMT; Low T3 syndrome; Nutritional status; Prognostic factors

Indexed keywords

3,3',5' TRIIODOTHYRONINE; LIOTHYRONINE; PREALBUMIN; THYROGLOBULIN; THYROTROPIN; THYROXINE; TRANSFERRIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; EUTHYROID SICK SYNDROME; FEMALE; FREE THYROXINE INDEX; GRIP STRENGTH; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THYROGLOBULIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0032421332     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701502     Document Type: Article

References (37)

1. Foerster J. Bone marrow transplantation. In: Lee GR, Bithell TC, Forester J, Athens JW, Linkens JW (eds). Wintrobe's Clinical Hematology. Lea & Febiger: Malvern, PA, 1993, pp 701-711.
2. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. New Engl J Med 1996; 316: 379-385.
3. Rady MY, Ryan T, Starr NJ. Clinical characteristics of pre-operative hypoalbuminemia predict outcome of cardiovascular surgery. J Paren Ent Nutr 1997; 21: 81-90.
4. Inoue Y, Nezu R, Matsuda H et al. Rapid turnover proteins as a prognostic indicator in cancer patients. Surg Today 1995; 25: 498-506.
5. Hunter RL, Bennett B, Garrison C et al. Transferrin in disease. I: A potential prognostic indicator in patients undergoing bone marrow transplantation. Am J Clin Pathol 1984; 81: 581-585.
6. Grant JP . Nutritional assessment in clinical practice. Nutr Clin Pract 1986; 3: 3-11.
7. Hill GL. The clinical assessment of adult patients with protein energy malnutrition. Nutr Clin Pract 1995; 10: 129-130.
8. Morgan SL. Identification of indicators for improving the diagnosis of malnutrition. Nutrition 1995; (Suppl.): 202-204.
9. Hebebrand J, Remschmidt H. Das Körpergewicht unter genetischen Aspekten. Med Klin 1995; 90: 403-410.
10. Hannan WJ, Wrate RM, Cowen SJ, Freeman CPL. Body mass index as an estimate of body fat. Int J Eat Dis 1995; 18: 91-97.
11. Bernstein L, Bachmann TE, Meguid M et al. Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Nutrition 1995; 11: 169-171.
12. Forse RA, Shizgal HM . Serum albumin and nutritional status. J Paren Ent Nutr 1980; 4: 450-454.
13. Spiekerman AM. Proteins used in nutritional assessment. Clin Lab Med 1993; 13: 353-369.
14. Docter D, Krenning EP, Jong de M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993; 39: 499-518.
15. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illnesses: the euthyroid sick syndrome. Endoc Rev 1982; 3: 164-217.
16. Reinhardt W, Mocker V, Jockenhövel F et al. The influence of coronary artery bypass surgery on thyroid hormone function. Horm Res 1997; 47: 1-8.
17. Wiersinga WM, Lie KI, Touber JL. Thyroid hormones in acute myocardial infarction. Clin Endocrinol 1981; 14: 367-374.
18. Reinhardt W, Holtermann D, Benker G, Olbricht T, Jaspers C, Reinwein D. Effect of small doses of iodine on thyroid function during caloric restriction in normal subjects. Horm Res 1993; 39: 132-137.
19. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol 1982; 16: 488-549.
20. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttail FQ, Shafer RB. Hypothyroxinaemia in critically ill patients as a predictor of high mortality. JAMA 1981; 245: 43-45.
21. Goldman JM. Modern approaches to management of chronic granulocytic leukemia. Semin Hematol 1978; 15: 420-430.
22. Kennedy BJ, Yarbro JW. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. JAMA 1966; 195: 1038-1043.
23. Mayer RJ. Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a 'best choice'? J Clin Oncol 1988; 6: 1532-1536.
24. Hoelzer D, Lindorp WD, Thiel E et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495-508.
25. Mayer RJ. Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia. Semin Oncol 1987; 14: 384-396.
26. Hoelzer D. Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 1984; 64: 38-47.
27. Beelen DW, Graeven U, Elmaagacli AH et al. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 1995; 85: 2981-2990.
28. Porayko MK, Wiesner RH, Krom RAF, Dickson ER, Beaver S, Schwerman L. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991; 23: 1462-1465.
29. Windsor JA, Hill GL. Grip strength: a measure of the proportion of protein loss in surgical patients. Br J Surg 1988; 75: 880-882.
30. Baron P, Waymack JP. A review of nutrition support for transplant patients. Nutr Clin Pract 1993; 8: 12-18.
31. Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. New Engl J Med 1985; 312: 546-552.
32. Vexiau P, Perez-Castiglioni P, Socie G et al. The 'euthyroid sick syndrome': incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. Br J Haematol 1993; 85: 778-782.
33. Kaptein EM, MacIntyre SS, Weiner JM, Spencer CA, Nicoloff JT. Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. J Clin Endocrinol Metab 1981; 52: 1073-1077.
34. Surks MI, Sievert R. Drugs and thyroid function. New Engl J Med 1995; 21: 1688-1694.
35. Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexamethasone on serum concentrations of 3,3′5-triiodthyronine (reverse T3) and 3,3′5-triiodthyronine (T3). J Clin Endocrinol Metab 1975; 41: 911-920.
36. Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F. The effect of glucocorticoid administration on human pituitary secretion on human secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 1976; 43: 338-346.
37. Brabant A, Brabant G, Schuermeyer T et al. The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol 1989; 121: 95-100.